Chongqing Pharscin Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 26.58 M

Chongqing Pharscin Pharmaceutical Co., Ltd. Current Liabilities is USD 26.58 M for the year ending December 31, 2023, a -13.22% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 30.62 M, a -5.99% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 32.57 M, a -16.88% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 39.19 M, a -9.97% change year over year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 43.53 M, a 20.24% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 002907.SZ

Chongqing Pharscin Pharmaceutical Co., Ltd.

CEO Ms. Xiaoying Liu
IPO Date Oct. 20, 2017
Location China
Headquarters No. 89, Middle Sec of Huangshan Ave
Employees 1,411
Sector Healthcare
Industries
Description

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.

StockViz Staff

February 3, 2025

Any question? Send us an email